ERα36 and GPERs can mediate breast cancer progression via non-genomic mitogenic oestrogen signalling and ultimate activation of the Nuclear factor erythroid 2-Related Factor 2 (NRF2) (Ishii and Warabi, 2019; Xu F. et al., 2023). This evidence concerns the gene NFE2L2 and breast carcinoma.